These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20183449)

  • 1. Last observation carried forward: a crystal ball?
    Kenward MG; Molenberghs G
    J Biopharm Stat; 2009 Sep; 19(5):872-88. PubMed ID: 20183449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A transition model for ordinal response data with random dropout: an application to the fluvoxamine data.
    Ghahroodi ZR; Ganjali M; Berridge D
    J Biopharm Stat; 2009 Jul; 19(4):658-71. PubMed ID: 20183432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline observation carry forward: reasoning, properties, and practical issues.
    Shao J; Jordan DC; Pritchett YL
    J Biopharm Stat; 2009 Jul; 19(4):672-84. PubMed ID: 20183433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modern statistical methods for handling missing repeated measurements in obesity trial data: beyond LOCF.
    Gadbury GL; Coffey CS; Allison DB
    Obes Rev; 2003 Aug; 4(3):175-84. PubMed ID: 12916818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missing data handling in chronic pain trials.
    Kim Y
    J Biopharm Stat; 2011 Mar; 21(2):311-25. PubMed ID: 21391004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Missing data perspectives of the fluvoxamine data set: a review.
    Molenberghs G; Goetghebeur EJ; Lipsitz SR; Kenward MG; Lesaffre E; Michiels B
    Stat Med; 1999 Sep 15-30; 18(17-18):2449-64. PubMed ID: 10474152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bias correction in testing treatment efficacy under informative dropout in clinical trials.
    Kong F; Chen YF; Jin K
    J Biopharm Stat; 2009 Nov; 19(6):980-1000. PubMed ID: 20183460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.
    Salim A; Mackinnon A; Christensen H; Griffiths K
    Psychiatry Res; 2008 Sep; 160(3):335-45. PubMed ID: 18718673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A joint model for nonlinear longitudinal data with informative dropout.
    Hu C; Sale ME
    J Pharmacokinet Pharmacodyn; 2003 Feb; 30(1):83-103. PubMed ID: 12800808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of longitudinal binary data with missing data due to dropouts.
    Ali MW; Talukder E
    J Biopharm Stat; 2005; 15(6):993-1007. PubMed ID: 16279357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVA.
    Mallinckrodt CH; Kaiser CJ; Watkin JG; Molenberghs G; Carroll RJ
    Clin Trials; 2004; 1(6):477-89. PubMed ID: 16279288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the random-effects pattern mixture model with last-observation-carried-forward (LOCF) analysis in longitudinal clinical trials with dropouts.
    Siddiqui O; Ali MW
    J Biopharm Stat; 1998 Nov; 8(4):545-63. PubMed ID: 9855033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparisons of methods for analysis of repeated binary responses with missing data.
    Frank Liu G; Zhan X
    J Biopharm Stat; 2011 May; 21(3):371-92. PubMed ID: 21442514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct likelihood analysis versus simple forms of imputation for missing data in randomized clinical trials.
    Beunckens C; Molenberghs G; Kenward MG
    Clin Trials; 2005; 2(5):379-86. PubMed ID: 16315646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian analysis of hierarchical pattern-mixture models for clinical trials data with attrition and comparisons to commonly used ad-hoc and model-based approaches.
    Demirtas H
    J Biopharm Stat; 2005; 15(3):383-402. PubMed ID: 15920887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Last observation carry-forward and last observation analysis.
    Shao J; Zhong B
    Stat Med; 2003 Aug; 22(15):2429-41. PubMed ID: 12872300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of practical approaches for handling missing data in clinical trials.
    DeSouza CM; Legedza AT; Sankoh AJ
    J Biopharm Stat; 2009 Nov; 19(6):1055-73. PubMed ID: 20183464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accounting for dropout bias using mixed-effects models.
    Mallinckrodt CH; Clark WS; David SR
    J Biopharm Stat; 2001; 11(1-2):9-21. PubMed ID: 11459446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eliciting and using expert opinions about dropout bias in randomized controlled trials.
    White IR; Carpenter J; Evans S; Schroter S
    Clin Trials; 2007; 4(2):125-39. PubMed ID: 17456512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials.
    Hedden SL; Woolson RF; Carter RE; Palesch Y; Upadhyaya HP; Malcolm RJ
    J Subst Abuse Treat; 2009 Jul; 37(1):54-63. PubMed ID: 19008067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.